A study looking at surovatamig for B cell acute lymphoblastic leukaemia (SYRUS)

This study is looking at surovatamig for B cell acute lymphoblastic leukaemia in young people and adults.

It is open to young people and adults with B cell acute lymphoblastic leukaemia (B cell ALL):

• that has come back after treatment (relapse)

• where treatment has stopped working (refractory)

You pronounce surovatamig as sur-roh-vah-tah-mig. Surovatamig is also called AZD0486.

Please note, we use the term ‘you’ in this summary. If you are a parent of a child with B cell acute lymphocytic leukaemia, we are referring to your child.